Work Here?
Overview
Subsense develops nanotechnology-based noninvasive brain-computer interfaces and medical devices aimed at treating neurodegenerative diseases. Its products are designed for daily, seamless use in healthcare, combining brain signal interfaces with nanotech to aid patients and clinicians. The company works with academic experts from ETH Zurich and Stanford to guide research and development, and plans to sell or license its BCI devices in Europe and the USA. Compared with competitors, Subsense emphasizes noninvasive, nano-scale interfaces and strong collaborations to translate research into market-ready medical devices. The overarching goal is to improve quality of life for individuals with neurodegenerative conditions by delivering practical, clinician-friendly BCI solutions.
About Subsense
Industries
Robotics & Automation
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$27M
Headquarters
California
Founded
N/A
People at Subsense
People at Subsense who can refer or advise you
Simplify's Take
What believers are saying
- With $27M total funding, Subsense accelerates nanoparticle sensing, biosafety, next-gen design, and hardware miniaturization.
- Therapeutic targets include Parkinson’s, Alzheimer’s, epilepsy, stroke recovery, depression, and chronic pain.
- Subsense plans pilot human trials by 2027 and aims to challenge Neuralink’s dominance with a safer alternative.
What critics are saying
- Neuralink’s $650M Series E and FDA-targeted 2029 Telepathy approval create a high knock-out risk by monopolizing clinical trials.
- Nasal nanoparticle delivery faces a high probability of in vivo biosafety failure by end-2027 due to unproven toxicity.
- Synchron’s FDA-cleared Stentrode with Nvidia AI integration erodes Subsense’s non-surgical advantage by capturing the same motor-restoration market.
What makes Subsense unique
- Subsense uses non-surgical, nasal nanoparticle delivery to cross the blood-brain barrier without implants.
- Its bidirectional BCI combines plasmonic nanoparticles for neural reading and magnetoelectric nanoparticles for stimulation.
- The company promises higher temporal and spatial resolution than invasive electrodes while avoiding surgical risks.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$27M
Above
Industry Average
Funded Over
2 Rounds
Growth & Insights and Company News
6 month growth
↓ -21%1 year growth
↓ -21%2 year growth
↓ -5%Subsense is developing a non-invasive, wearable BCI system.
Subsense is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Subsense
Industries
Robotics & Automation
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$27M
Headquarters
California
Founded
N/A
Subsense is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today